The ownership structure of Enzon Pharmaceuticals (ENZN) stock is a mix of institutional, retail and individual investors. Approximately <0.01% of the company’s stock is owned by Institutional Investors, 13.75% is owned by Insiders and 86.25% is owned by Public Companies and Individual Investors.
The ownership structure of Enzon Pharmaceuticals (ENZN) stock is a mix of institutional, retail and individual investors. Approximately <0.01% of the company’s stock is owned by Institutional Investors, 13.75% is owned by Insiders and 86.25% is owned by Public Companies and Individual Investors.
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 13.75% is held by insiders, and 86.25% is held by retail investors.
What percentage of Enzon Pharmaceuticals (ENZN) stock is held by institutional investors?
According to the latest TipRanks data, approximately <0.01% of Enzon Pharmaceuticals (ENZN) stock is held by institutional investors.
What percentage of Enzon Pharmaceuticals (ENZN) stock is held by retail investors?
According to the latest TipRanks data, approximately 86.25% of Enzon Pharmaceuticals (ENZN) stock is held by retail investors.
Who owns the most shares of Enzon Pharmaceuticals (ENZN)?
Carl Icahn owns the most shares of Enzon Pharmaceuticals (ENZN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.